INCLUDE_DATA

NF Smarty Pants

A collection of the latest news, events, and information about Neurofibromatosis
July 1st, 2009

PTC Therapeutics Inc. Receives Grant For NF2 Drug Development

PTC Therapeutics Inc. received $.82 million from the Department of Defense further their research into a drug treatment for NF2. Drug candidate PTC299 is ready to go into Phase 2 clinical trial.

Posted in Research |

This entry was posted on Wednesday, July 1st, 2009 at 9:55 am and is filed under Research. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.

Comments are closed.